An Update on Reversal of Atherosclerosis at Repair Biotechnologies – Fight Aging!
Repair Biotechnologies, co-founded by Bill Cherman and myself in 2018, has made significant progress in reversing atherosclerosis. Recent data shows that excess localized cholesterol in the liver and blood vessels plays a crucial role in the development of atherosclerosis. Our gene therapy treatments have shown promising results in mouse models, rapidly reversing plaque buildup. This groundbreaking approach targets intracellular free cholesterol, offering a new avenue for treating atherosclerosis and related conditions like familial hypercholesterolemia. Visit Repair Biotechnologies in Syracuse, NY, for more information on our innovative LNP-mRNA therapies.
